Skip to main content
. Author manuscript; available in PMC: 2018 Jun 1.
Published in final edited form as: Adv Mater. 2017 Mar 29;29(23):10.1002/adma.201606857. doi: 10.1002/adma.201606857

Table 7.

Slight acid-driven turn on theranostics.

pH of acid Bioactive link/group Signal reporter Therapeutic agent Imaging modality Therapeutic modality Ref.
6.8 Diethylaminopropyl Ce6 Ce6 FLI PDT 188
5.0 Dimethylaminophenyl Rubyrin Rubyrin FLI PDT 189
5.5 Ethylene amide AuNPs AuNPs RAI PTT 190
6.8 Dimethylmaleic acid UCNP@2xCe6 UCNP@2xCe6 FLI PDT 191
6.0 MnO2 Mn2+ DOX MRI CHT 192
5.0 DOX@HA DOX DOX FLI CHT 193
5.5 Diethylamino BODIPY Paclitaxel FLI CHT 194
5.0 PPy@SiO2@dRB dRB PPy FLI PTT 195
4.5 Calcium phosphate NaGdF4:Ce/Tb DOX FLI/MRI CHT 196
5.0 2-aminophenol BDP-688 R16FP FLI PDT 197
5.3 Chitosan CurP-SeNPs CurP-SeNPs FLI CHT 198
5.0 Diisopropylamino AIEgen/PheA PheA FLI PDT 199
6.5 Imidazole Ir(NC)2(NN)PF6 Ir(NC)2(NN)PF6 FLI PDT 200
5.0 Diethylaminophenyl BODIPY BODIPY FLI PDT 201
6.5 Dopamine Fe3+ Polydopamine MRI PTT 202
6.0 Phenyl amine DOX DOX FLI CHT 203
5.8 Chitosan DOX/CDs DOX/CDs FLI CHT/PTT 204
5.4 MnAsOx complexes Mn2+ HAsO32− MRI CHT 205
5.0 Fe3+-gallic acid Fe-CPNDs Fe-CPNDs MRI PTT 206
6.5 Croconaine Croconaine Croconaine PAI PTT 207
6.2 Diamine Ce6 HOT/Ce6 FLI CHT/PDT 208
6.0 Hydrazone IR825 DOX/ IR825 FLI CHT/PTT 209
6.5 CaCO3 Ce6(Mn) Ce6(Mn)/DOX MRI/FLI CHT/PDT 210
6.2 Amine moiety Hcyanine Hcyanine FLI PTT 211
5.0 Hydrazone AIEgen DOX FLI CHT 212
6.0 Hydrazone SiPc SiPc FLI PDT 213
5.0 Amine Au DOX/Au CT CHT/PTT 214
5.0 Dimethylamino BODIPY DOX FLI CHT 215
6.5 LDH ZnPc ZnPc FLI PDT 216
6.8 Imidazole Fe3O4/Ce6 Ce6 MRI/FLI PDT 217
6.2 Tertiary amine PDPA-Ce6/Gd3+ PDPA-Ce6/DOX FLI/PAI/MRI PDT/PTT/CHT 218
6.2 Tertiary amine PPa PPa/SiRNA FLI PDT/Immunotherapy 219